STOK

STOKE THERAPEUTICS INC

STOK·86150R107·US·Common Stock·Healthcare - Biotechnology-13D/G

STOK (STOKE THERAPEUTICS INC) is held by 118 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($183.1M), BlackRock, Inc. ($175.4M), FMR LLC ($175.3M). Net institutional sentiment: Mixed.

118
Holders
(10 Elite)
$1.7B
Total Value
63% (121)
Consensus
76 buying - 45 selling
13F: Insider & Congress:
STOK

Smart Money Verdict

View all
Held by 118 funds
10 elite

Who's Trading

InsiderTBTicho BarrySell $219KJul 1, 2026
InsiderTBTicho BarrySell $17KJul 1, 2026
InsiderAJAllan JonathanSell $44KJun 16, 2026
ActivistLYLynx1 Capital Management LP8.1%May 18, 2026
ActivistRERedmile Group, LLC6.7%May 15, 2026
ActivistRTW Investments, LPRTW Investments, LP9.9%May 15, 2026
ActivistWellington Management Group LLPWellington Management Group LLP5.2%May 15, 2026
ActivistThe Toronto-Dominion BankThe Toronto-Dominion Bank5.4%May 15, 2026
InsiderTBTicho BarrySell $74KMay 1, 2026
InsiderTBTicho BarrySell $60KApr 1, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
5.6M(+1.4%)$183.1M1.8%+31.59%
49
Increased
5.4M(+3.3%)$175.4M0.0%+168.46%
31
Decreased
5.4M(-3.9%)$175.3M0.0%+207.82%
0
Decreased
3.4M(-3.5%)$111.5M0.0%+139.93%
0
Unchanged
3.3M$108.6M0.6%+183.75%
0
Unchanged
3.2M$103.3M0.1%+190.56%
0
Increased
3.1M(+320.7%)$100.8M0.0%+0.80%
48
New
2.4M$76.7M0.0%-7.10%
41
Decreased
2.3M(-8.9%)$74.1M0.0%+58.24%
0
Increased
1.9M(+419.5%)$63M0.0%-4.57%
48
Increased
1.6M(+11.2%)$52.5M0.0%+4.46%
33
Increased
1.3M(+13.4%)$43.1M0.0%+38.37%
33
Decreased
1.1M(-10.8%)$36.9M0.1%+96.33%
0
Increased
989,936(+19.7%)$32.2M0.0%+84.28%
34
Decreased
907,015(-26.1%)$29.5M0.0%+55.88%
0
Decreased
830,702(-27.3%)$27M0.0%+208.65%
0
Increased
575,182(+133.0%)$18.7M0.0%-4.73%
46
Increased
543,095(+163.4%)$17.7M0.0%+32.05%
46
Increased
502,020(+12.4%)$16.3M0.1%-2.05%
32
New
472,141$15.4M0.0%-7.10%
39

Showing 1-20 of 128

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used